Sunday, September 29, 2024
HomeTagsU.S. IND Approval

U.S. IND Approval

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

Ascletis Pharma Inc.  announces the approval of the Investigational New Drug (IND) application by U.S. Food and Drug Administration (FDA) for in-house developed oral...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics